- Home
- IRBT vs AVIR Comparison
IRBT vs AVIR Comparison
Compare IRBT & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- AVIR
- Stock Information
- Founded
- IRBT 1990
- AVIR 2012
- Country
- IRBT United States
- AVIR United States
- Employees
- IRBT N/A
- AVIR N/A
- Industry
- IRBT Consumer Electronics/Appliances
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- IRBT Consumer Discretionary
- AVIR Health Care
- Exchange
- IRBT Nasdaq
- AVIR Nasdaq
- Market Cap
- IRBT 267.4M
- AVIR 247.5M
- IPO Year
- IRBT N/A
- AVIR 2020
- Fundamental
- Price
- IRBT $7.43
- AVIR $3.29
- Analyst Decision
- IRBT Hold
- AVIR Hold
- Analyst Count
- IRBT 2
- AVIR 1
- Target Price
- IRBT $13.00
- AVIR $6.88
- AVG Volume (30 Days)
- IRBT 1.1M
- AVIR 491.5K
- Earning Date
- IRBT 11-06-2024
- AVIR 11-07-2024
- Dividend Yield
- IRBT N/A
- AVIR N/A
- EPS Growth
- IRBT N/A
- AVIR N/A
- EPS
- IRBT N/A
- AVIR N/A
- Revenue
- IRBT $817,355,000.00
- AVIR N/A
- Revenue This Year
- IRBT N/A
- AVIR N/A
- Revenue Next Year
- IRBT N/A
- AVIR N/A
- P/E Ratio
- IRBT N/A
- AVIR N/A
- Revenue Growth
- IRBT N/A
- AVIR N/A
- 52 Week Low
- IRBT $5.83
- AVIR $2.75
- 52 Week High
- IRBT $39.17
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- IRBT 41.30
- AVIR 49.07
- Support Level
- IRBT $8.07
- AVIR $3.10
- Resistance Level
- IRBT $9.33
- AVIR $3.27
- Average True Range (ATR)
- IRBT 0.66
- AVIR 0.16
- MACD
- IRBT -0.13
- AVIR 0.02
- Stochastic Oscillator
- IRBT 5.63
- AVIR 55.28
About IRBT iRobot Corporation
iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).